A case-control association study of serotonin 1A receptor gene and tryptophan hydroxylase 2 gene in attention deficit hyperactivity disorder
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shim, Se-Hoon | - |
dc.contributor.author | Hwangbo, Young | - |
dc.contributor.author | Kwon, Young-Joon | - |
dc.contributor.author | Jeong, Hee-Yeon | - |
dc.contributor.author | Lee, Bun-Hee | - |
dc.contributor.author | Hwang, Jung-A | - |
dc.contributor.author | Kim, Yong-Ku | - |
dc.date.accessioned | 2021-09-08T00:52:53Z | - |
dc.date.available | 2021-09-08T00:52:53Z | - |
dc.date.created | 2021-06-14 | - |
dc.date.issued | 2010-08-16 | - |
dc.identifier.issn | 0278-5846 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/115874 | - |
dc.description.abstract | Serotonergic system-related genes are likely to be involved in mechanisms underlying attention deficit hyperactivity disorder (ADHD). We investigated the association of serotonin the 1A receptor C-1019G single nucleotide polymorphism (HTR1A C-1019G SNP) and tryptophan hydroxylase 2 gene -703GIT (TPH2 - 703G/T) SNP with ADHD. All of the ADHD subjects completed a comprehensive and standardized diagnostic and psychological evaluation battery including the parents' Korean version of the ADHD Rating Scale-IV (ARS). The genotype and allele frequencies of 78 ADHD patients and 107 normal controls were analyzed for 5-HTR1A C-1019G and TPH2 -703G/T. There were statistically significant differences in the genotype distributions and allele frequencies of FITR1A C-1019G between the ADHD group and the control group. The homozygous allele C frequency was significantly higher in ADHD patients than in controls. However, no differences in either genotype distribution or in allele frequencies of TPH2 -703G1T were observed between the ADHD patients and the controls. In the ADHD patients, ANCOVA revealed that there were no significant differences in the subscales and total score between the ADHD probands with the CC genotype and those with the CG and GG genotypes in ARS and the Continuous Performance Test (CPT) when adjusting for age and gender. The odds ratio comparing the CC genotype group with the CG genotype group and the C allele with G was 2.12 and 1.79 respectively. Therefore, genotype CC was associated with higher risk of ADHD. Our results suggest that the H1'R1A C-1019G SNP may affect susceptibility to ADHD. Further investigation with a larger number of subjects is needed in order to confirm this finding. (C) 2010 Elsevier Inc. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.subject | DEFICIT/HYPERACTIVITY DISORDER | - |
dc.subject | TRANSCRIPTIONAL REGULATION | - |
dc.subject | SUSTAINED ATTENTION | - |
dc.subject | LOCOMOTOR-ACTIVITY | - |
dc.subject | POLYMORPHISM | - |
dc.subject | ADHD | - |
dc.subject | VARIANTS | - |
dc.subject | PERSONALITY | - |
dc.subject | EXPRESSION | - |
dc.subject | CHILDREN | - |
dc.title | A case-control association study of serotonin 1A receptor gene and tryptophan hydroxylase 2 gene in attention deficit hyperactivity disorder | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Yong-Ku | - |
dc.identifier.doi | 10.1016/j.pnpbp.2010.05.006 | - |
dc.identifier.scopusid | 2-s2.0-77955051394 | - |
dc.identifier.wosid | 000281187800025 | - |
dc.identifier.bibliographicCitation | PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, v.34, no.6, pp.974 - 979 | - |
dc.relation.isPartOf | PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY | - |
dc.citation.title | PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY | - |
dc.citation.volume | 34 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 974 | - |
dc.citation.endPage | 979 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Psychiatry | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Psychiatry | - |
dc.subject.keywordPlus | DEFICIT/HYPERACTIVITY DISORDER | - |
dc.subject.keywordPlus | TRANSCRIPTIONAL REGULATION | - |
dc.subject.keywordPlus | SUSTAINED ATTENTION | - |
dc.subject.keywordPlus | LOCOMOTOR-ACTIVITY | - |
dc.subject.keywordPlus | POLYMORPHISM | - |
dc.subject.keywordPlus | ADHD | - |
dc.subject.keywordPlus | VARIANTS | - |
dc.subject.keywordPlus | PERSONALITY | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | CHILDREN | - |
dc.subject.keywordAuthor | ADHD | - |
dc.subject.keywordAuthor | Attention deficit hyperactivity disorder | - |
dc.subject.keywordAuthor | Serotonin 1A receptor | - |
dc.subject.keywordAuthor | TPH | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.